The FDA is mandating new labeling for opioids to better inform patients and healthcare providers about the risks of addiction, misuse, and overdose associated with long-term use.

A panel organized by the FDA cast doubts on the safety of antidepressants during pregnancy — drawing ire from doctors who say ...

These energy drinks, gummies, and supplements legally sold at gas stations and convenience stores here in the Lehigh Valley and all across the country contain an ingredient more potent than ...

The FDA has released a report to educate the public regarding the dangers of 7-OH and its distinction from the kratom plant ...

FDA mandates new opioid labeling to highlight long-term risks, aiming to combat addiction and improve patient safety in pain ...

The U.S. Food and Drug Administration plans to require new labels on all opioid pain medications that emphasizes long-term ...

Laura Loomer reportedly set up a "tip line" for staffers eager to see their "disloyal" colleagues purged. Trump has been ...

President Donald Trump surprised pharma CEOs on Thursday with letters demanding they acquiesce to his most-favored ...

The changes, required for safety labeling of all opioid drugs, will emphasize the risks with long-term use to combat misuse ...

The FDA is recommending that certain products containing 7-hydroxymitragynine be subject to the Controlled Substances Act.